4.7 Article

The comprehensive analysis of thalassemia alleles (CATSA) based on single-molecule real-time technology (SMRT) is a more powerful strategy in the diagnosis of thalassemia caused by rare variants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Laboratory Technology

Back-to-Back Comparison of Third-Generation Sequencing and Next-Generation Sequencing in Carrier Screening of Thalassemia

Renliang Huang et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2023)

Article Medical Laboratory Technology

Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia

Qiaowei Liang et al.

Summary: This study evaluates the clinical utility of CATSA, a long-read sequencing-based approach, in prenatal diagnosis of thalassemia. The results show that CATSA can detect variants more accurately than PCR methods, correct predicted phenotypes, and potentially improve clinical outcomes. This suggests that CATSA is a comprehensive and accurate approach that can provide more informative genetic counseling and improved clinical outcomes.

CLINICAL CHEMISTRY (2023)

Article Genetics & Heredity

The value of single-molecule real-time technology in the diagnosis of rare thalassemia variants and analysis of phenotype-genotype correlation

Shiqiang Luo et al.

Summary: Comparing single-molecule real-time technology (SMRT) with conventional genetic diagnostic technology for rare thalassemia mutations, a study was conducted on 434 cases using both methods. SMRT was able to identify a higher number of variants compared to conventional technology, with a 9.91% increase in positive detection rate. The combination of both methods detected 485 positive alleles among 49 types of variant, and SMRT was able to identify some variants not detected by conventional methods, highlighting its significance in clinical thalassemia gene screening.

JOURNAL OF HUMAN GENETICS (2022)

Article Pathology

A More Universal Approach to Comprehensive Analysis of Thalassemia Alleles (CATSA)

Qiaowei Liang et al.

Summary: The study evaluated the clinical utility of a third-generation sequencing approach, CATSA, for diagnosing thalassemia genetic carriers. CATSA effectively identified pathogenic thalassemia variants, including rare ones, improving diagnostic accuracy for carriers.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

Review Medical Laboratory Technology

Thalassemia in the laboratory: pearls, pitfalls, and promises

Gunay Aliyeva et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome

Aaron M. Wenger et al.

NATURE BIOTECHNOLOGY (2019)

Article Oncology

Clinical Classification, Screening and Diagnosis for Thalassemia

Vip Viprakasit et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)

Review Medicine, General & Internal

Thalassaemia

Ali T. Taher et al.

LANCET (2018)

Article Biochemistry & Molecular Biology

Rare α0-thalassemia deletions detected by MLPA in five unrelated Brazilian patients

Natalia O. Mota et al.

GENETICS AND MOLECULAR BIOLOGY (2017)

Article Hematology

Laboratory diagnosis of thalassemia

V. Brancaleoni et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)

Article Biochemistry & Molecular Biology

Two novel copy number variations involving the α-globin gene cluster on chromosome 16 cause thalassemia in two Chinese families

Lingling Hu et al.

MOLECULAR GENETICS AND GENOMICS (2016)

Review Hematology

State of the art and new developments in molecular diagnostics for hemoglobinopathies in multiethnic societies

C. L. Harteveld

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)

Article Biochemistry & Molecular Biology

Updates of the HbVar database of human hemoglobin variants and thalassemia mutations

Belinda Giardine et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Multidisciplinary Sciences

IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology

Petros Kountouris et al.

PLOS ONE (2014)

Article Hematology

A novel 506 kb deletion causing εγδβ thalassemia

Helen Rooks et al.

BLOOD CELLS MOLECULES AND DISEASES (2012)

Article Biochemistry & Molecular Biology

High prevalence of the -alpha(3.7) deletion among Thalassemia patients in Iran

M Neishabury et al.

HEMOGLOBIN (2003)

Article Medicine, General & Internal

Genetic and clinical features of hemoglobin H disease in Chinese patients

FE Chen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)